Decoupling of Gray and White Matter Functional Networks in Medication-Naïve Patients With Major Depressive Disorder

Youjin Zhao1, Feifei Zhang1, Wenjing Zhang1

  • 1Huaxi MR Research Center (HMRRC), Department of Radiology, West China Hospital of Sichuan University, Chengdu, China.

Abstract

Insights

Major depressive disorder (MDD) is linked to reduced functional connectivity (FC) between gray matter (GM) and white matter (WM) networks. These disruptions in brain networks may underlie the symptoms of MDD.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Medical Imaging

Background:

  • Major depressive disorder (MDD) is increasingly viewed as a disconnection syndrome.
  • Previous research primarily focused on gray matter (GM) functional connectivity (FC) alterations.
  • Functional alterations in white matter (WM) in MDD remain understudied.

Purpose of the Study:

  • To investigate functional alterations in white matter (WM) in medication-naïve patients with major depressive disorder (MDD).
  • To examine the functional interactions between GM and WM networks in MDD.

Main Methods:

  • Utilized resting-state functional MRI (fMRI) at 3.0T to acquire blood oxygenation level-dependent (BOLD) signals.
  • Employed K-means clustering to identify functional GM and WM networks.
  • Analyzed functional connectivity (FC) matrices using statistical tests including two-sample t-tests and Pearson correlation.

Main Results:

  • Reduced FC was observed between visual and sensorimotor/lateral temporal/cingulo-opercular/dorsal attention networks in both GM and WM in MDD patients compared to controls.
  • Further reductions in FC were found between anterior cingulum, temporal pole, medial temporal, and medial prefrontal-subcortical networks in MDD.
  • WM BOLD signal in the sensorimotor network negatively correlated with illness duration in MDD patients.

Conclusions:

  • Disconnectivity between GM and WM networks, particularly in perception-motor systems, may form the basis of widespread network disruption in MDD.
  • Observed decoupling within default mode network subsystems could explain persistent negative rumination and theory of mind deficits in depression.

Related Concept Videos

Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
387
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
320
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
643
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.1K